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Introduction

Case Study

Signs & Symptoms

Neonatal jaundice is a common
condition present in infants after birth. It is
caused by elevated bilirubin in the blood.
It can affect up to 84% of term infants and
is one of the most common cause for
hospital readmission for the neonatal
department (Muchowski, 2014). It typically
appears within 24 hours of life and is
normally present in otherwise healthy
newborns. Physiologic jaundice, also
known as unconjugated bilirubin, is a
normal process that happens in neonates
because the hepatic system is not matured
yet (Kirk, 2008). Majority of the time
physiologic jaundice resolves on its own.
Pathological jaundice, also known as
conjugated bilirubin, in newborns is due to
other reasons other than the normal
pathologic process the newborn hepatic
system goes through. It may be a result of
endocrine or genetic disorders, which are
considered to be rare (Kirk, 2008). A more
common cause is due to ABO
incompatibility. For the purpose of this
poster the focus is going to be on
pathologic elevated bilirubin specifically
related to ABO incompatibility between
mother and baby.

A mother who was O blood type and
had a term baby with A+ blood type and
was admitted to the NICU for elevated
bilirubin levels of 10mg/dl. The mother
was wanting to understand why her baby
had yellowed skin color. It was explained
to the mother that she makes antibodies
against blood type A and blood type B and
the antibodies are able to cross the
placenta destroying the baby’s RBC’s.
When RBC’s are destructed there is a rise
in the bilirubin levels manifesting by
causing a yellowish tint to the infants skin
color (Rubarth, 2011). In this particular
study knowing the mother was O blood
type that meant there were three blood
type possibilities for the father. The
below table shows the three genotype
possibilities for the father that would
result in the infant have an A+ blood type.

Visual inspection may be the first
noticeable sign that an infant maybe have
pathologic jaundice but is not the most
accurate method to determine elevated
bilirubin levels. Trying to estimate serum
bilirubin by using clinical examination is not
reliable and therefore not recommended
(Dennery, Seidman, Stevenson, 2001).
Jaundice is defined as the yellow-orange
discoloration found in the sclera, skin, and
other tissues of infants (Schwartz,
Haberman, & Ruddy, 2011). Jaundice is
hard to observe in dark skin babies. Even
though jaundice may indicate an imbalance
of production and elimination of bilirubin it
does not imply any specific cause (Cohen,
Wong, & Stevenson, 2010). It is
recommended that babies that appear to
look jaundice or have risk factors should be
evaluated using total serum bilirubin (TSB)
or transcutaneous bilirubin (TcB).
Performing both the universal TSB/TcB
screening along with using the risk factor
scoring system seems to be the most
reliable method for identifying infants at
high risk for hyperbilirubinemia. Detection
of those infants that are at high risk for
increased bilirubin levels allows for earlier
treatment options leading to improved
clinical outcomes (Muchowski, 2014).

Pathophysiology
ABO incompatibility can happen between a mother and baby primarily
when the mother has blood type O and the developing fetus has blood type
A, B, or AB. This happens because mothers with type O blood have anti-A
and anti-B antibodies because the baby has A, B, or AB blood type. These
antibodies cross the placenta and go into the fetal circulation. The
antibodies then attach to the infant’s red blood cells (RBC’s) causing
hemolysis of the RBC’s. The attaching and attacking by the antibodies
starts while the baby is still in utero. Hemolysis of RBC’s cause an increase
in bilirubin levels. In order for hemolysis to occur the antibodies have to
attach to the RBC’s (Rubarth, 2011).

Table 1. Three possible genotypes for the father in the case study (Rubarth, 2011)
Genotypes of Parents

Mother’s Blood Type
(O)

Mother’s Blood Type
(O)

Father’s Blood Type (A)

O

O

A

AO

AO

A

AO

AO

Genotypes of Parents

Mother’s Blood Type
(O)

Mother’s Blood Type
(O)

Father’s Blood Type (A)

O

O

A

AO

AO

O

OO

OO

Genotypes of Parents

Mother’s Blood Type
(O)

Mother’s Blood Type
(O)

Father’s Blood Type (AB)

O

O

A

AO

AO

B

BO

BO

Significance of Pathophysiology

Implications to
Nursing
Nurses are the front line to caring for
mothers and infants that might have
conjugated elevated bilirubin. Nurses play
an important role in promoting follow-up,
assessing infants for risk factors, assessing
jaundice level using the TSB or TcB (Wells,
Ahmed, & Musser, 2013). Many hospitals
do not allow nurses to independently
check bilirubin levels without a physician
order. Therefore this can create a barrier
to diagnosing hyperbilirubinemia. If there
was a system in place to allow the nurses
to check the bilirubin levels of infants
based on certain risk factors or clinical
suspicion might help diagnose
hyperbilirubinemia before it becomes lifethreatening. Follow-up is important
because infants are being discharged
sooner making them not available to
healthcare workers when the bilirubin
levels peak. Having a protocol in place for
when infants are discharged may help to
ensure follow-up bilirubin testing. The
parents must understand the potential
risk with hyperbilirubinemia and that is
where the nurse can play a strong role
(Bhutani, Schwoebel, & Gennaro, 2006). It
is important that nurses stay up to date on
completing ongoing education and passing
required competencies in order to provide
the best possible care to the patients.
Nurses should be well educated about
conjugated hyperbilirubinemia in order to
properly educate the parents of the babies
diagnosed with elevated bilirubin and
answer any questions they might have.

Conclusion
Even though jaundice can be a
normal physiological process that
newborns go through it is important to
determine whether it has a pathologic
component to it in order to properly
monitor and treat it. If not properly
diagnosed and treated than the risk of
developing long term neurological
damage is increased. It is important to
be able to know what to look for and
know the risks associated with
hyperbilirubinemia no matter if
working in an inpatient or outpatient
setting. Early evaluation of infants is
important to help determine diagnosis
of pathologic hyperbilirubinemia
before the baby is discharged home.
Once discharge it is important to have
a follow-up appointment scheduled
within two to three days after
discharge so the infant can be
professionally examined for jaundice
(Dennery, et al., 2001).

Significance of Pathophysiology
The primary reason that healthcare workers assess for
hyperbilirubinemia is because of the chance of neurotoxic effects (Dennery,
et al., 2001). This can happen by the bilirubin crossing the blood-brain
barrier and entering the brain tissue (Lauer & Spector, 2011). When this
happens it poses a risk of developing neurological dysfunction (Stevenson,
Vreman, & Wong, 2011). Kernicterus is the term used to describe the
permanent development of bilirubin toxicity (Schwartz, et al., 2011).
Bilirubin can only enter the brain if it is not bound to albumin or is
unconjugated (Dennery, et al., 2001). If the babies serum albumin level is
low this causes the binding of bilirubin to be compromise leading to an
increase chance of kernicterus (Dennery, et al., 2001). Even though
kernicterus is not seen very much anymore it is still important to continue
to prevent it by being meticulous in assessing and treating elevated levels
of bilirubin (Dennery, et al., 2001).
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